Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Overview of studies of the vitamin D/vitamin D receptor system in the development of non-alcoholic fatty liver disease.

Cimini FA, Barchetta I, Carotti S, Morini S, Cavallo MG.

World J Gastrointest Pathophysiol. 2019 Sep 10;10(2):11-16. doi: 10.4291/wjgp.v10.i2.11.

2.

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.

Barchetta I, Enhörning S, Cimini FA, Capoccia D, Chiappetta C, Di Cristofano C, Silecchia G, Leonetti F, Melander O, Cavallo MG.

BMC Med. 2019 Apr 30;17(1):85. doi: 10.1186/s12916-019-1319-4.

3.

Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity.

Cimini FA, Arena A, Barchetta I, Tramutola A, Ceccarelli V, Lanzillotta C, Fontana M, Bertoccini L, Leonetti F, Capoccia D, Silecchia G, Di Cristofano C, Chiappetta C, Di Domenico F, Baroni MG, Perluigi M, Cavallo MG, Barone E.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1490-1501. doi: 10.1016/j.bbadis.2019.02.021. Epub 2019 Feb 28.

PMID:
30826467
4.

Increased circulating granzyme B in type 2 diabetes patients with low-grade systemic inflammation.

Cimini FA, D'Eliseo D, Barchetta I, Bertoccini L, Velotti F, Cavallo MG.

Cytokine. 2019 Mar;115:104-108. doi: 10.1016/j.cyto.2018.11.019. Epub 2018 Nov 22.

PMID:
30473178
5.

Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes.

Bertoccini L, Bailetti D; SUMMER Study in Diabetes Group, Buzzetti R, Cavallo MG, Copetti M, Cossu E, D'Angelo P, De Cosmo S, Di Mauro L, Leonetti F, Morano S, Morviducci L, Napoli N, Prudente S, Pugliese G, Trischitta V, Baroni MG.

Oncotarget. 2018 Oct 9;9(79):34911-34918. doi: 10.18632/oncotarget.26178. eCollection 2018 Oct 9.

6.

Technological Support to Intensive Insulin Therapy by a Novel Smartphone Application in Young Adults With Type 1 Diabetes: One Center's Experience.

Barchetta I, Cavallo MG.

J Diabetes Sci Technol. 2019 Jan;13(1):148-149. doi: 10.1177/1932296818803937. Epub 2018 Oct 7. No abstract available.

7.

Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.

Beveridge LA, Khan F, Struthers AD, Armitage J, Barchetta I, Bressendorff I, Cavallo MG, Clarke R, Dalan R, Dreyer G, Gepner AD, Forouhi NG, Harris RA, Hitman GA, Larsen T, Khadgawat R, Marckmann P, Mose FH, Pilz S, Scholze A, Shargorodsky M, Sokol SI, Stricker H, Zoccali C, Witham MD.

J Am Heart Assoc. 2018 May 30;7(11). pii: e008273. doi: 10.1161/JAHA.117.008273.

8.

Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity.

Barchetta I, Cimini FA, Capoccia D, Bertoccini L, Ceccarelli V, Chiappetta C, Leonetti F, Di Cristofano C, Silecchia G, Orho-Melander M, Melander O, Cavallo MG.

Nutrients. 2018 Apr 23;10(4). pii: E526. doi: 10.3390/nu10040526.

9.

Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.

Barchetta I, Cimini FA, Leonetti F, Capoccia D, Di Cristofano C, Silecchia G, Orho-Melander M, Melander O, Cavallo MG.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2253-2260. doi: 10.1210/jc.2017-02751.

PMID:
29590379
10.

WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes.

Barchetta I, Cimini FA, Capoccia D, De Gioannis R, Porzia A, Mainiero F, Di Martino M, Bertoccini L, De Bernardinis M, Leonetti F, Baroni MG, Lenzi A, Cavallo MG.

J Endocr Soc. 2017 Apr 18;1(6):660-670. doi: 10.1210/js.2017-00108. eCollection 2017 Jun 1.

11.

The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.

Bertoccini L, Sentinelli F, Incani M, Bailetti D, Cimini FA, Barchetta I, Cavallo MG, Cossu E, Lenzi A, Loche S, Baroni MG.

Lipids Health Dis. 2017 Sep 19;16(1):179. doi: 10.1186/s12944-017-0569-4.

12.

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future.

Barchetta I, Cimini FA, Cavallo MG.

Nutrients. 2017 Sep 14;9(9). pii: E1015. doi: 10.3390/nu9091015. Review.

13.

Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.

Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-Gentilucci U, Cavallo MG, Morini S.

World J Gastroenterol. 2017 May 21;23(19):3407-3417. doi: 10.3748/wjg.v23.i19.3407. Review.

14.

Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.

Barchetta I, Angelico F, Del Ben M, Di Martino M, Cimini FA, Bertoccini L, Polimeni L, Catalano C, Fraioli A, Del Vescovo R, Morini S, Baroni MG, Cavallo MG.

Clin Sci (Lond). 2016 Oct 1;130(19):1753-62. doi: 10.1042/CS20160348. Epub 2016 Jul 25.

PMID:
27458255
15.

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

Barchetta I, Del Ben M, Angelico F, Di Martino M, Fraioli A, La Torre G, Saulle R, Perri L, Morini S, Tiberti C, Bertoccini L, Cimini FA, Panimolle F, Catalano C, Baroni MG, Cavallo MG.

BMC Med. 2016 Jun 29;14:92. doi: 10.1186/s12916-016-0638-y.

16.

Search for Genetic Variant in the Apelin Gene by Resequencing and Association Study in European Subjects.

Sentinelli F, Capoccia D, Bertoccini L, Barchetta I, Incani M, Coccia F, Manconi E, Lenzi A, Cossu E, Leonetti F, Cavallo MG, Baroni MG.

Genet Test Mol Biomarkers. 2016 Feb;20(2):98-102. doi: 10.1089/gtmb.2015.0260. Epub 2016 Jan 20.

PMID:
26789934
17.

Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study.

Di Franco M, Barchetta I, Iannuccelli C, Gerardi MC, Frisenda S, Ceccarelli F, Valesini G, Cavallo MG.

BMC Musculoskelet Disord. 2015 Mar 15;16:53. doi: 10.1186/s12891-015-0505-6.

18.

Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control.

Barchetta I, Guglielmi C, Bertoccini L, Calella D, Manfrini S, Secchi C, Pozzilli P, Cavallo MG; IMDIAB group.

Acta Diabetol. 2015 Oct;52(5):873-80. doi: 10.1007/s00592-015-0721-4. Epub 2015 Feb 27.

PMID:
25716766
19.

Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization.

Incani M, Sentinelli F, Perra L, Pani MG, Porcu M, Lenzi A, Cavallo MG, Cossu E, Leonetti F, Baroni MG.

J Diabetes Investig. 2015 Jan;6(1):44-50. doi: 10.1111/jdi.12241. Epub 2014 May 16.

20.

Hypovitaminosis D is independently associated with metabolic syndrome in obese patients.

Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, Fraioli A, Morini S, Leonetti F, Cavallo MG.

PLoS One. 2013 Jul 31;8(7):e68689. doi: 10.1371/journal.pone.0068689. Print 2013.

Supplemental Content

Loading ...
Support Center